Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 137941000087117 | Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | en | Fully specified name | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 29531000087118 | Inf Arepanrix GSK | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 29551000087110 | Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway English module (core metadata concept) |
| 72861000087116 | Inf Arepanrix GSK | fr | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | Canada Health Infoway French module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | Has supplier | GlaxoSmithKline Inc. (supplier) | true | Inferred relationship | Some | ||
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | a pour principe actif (attribut) | Antigen of Influenza A virus subtype H1N1 split virion (substance) | true | Inferred relationship | Some | 1 | |
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | est un(e) (attribut) | Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | Count of active ingredient | un | false | Inferred relationship | Some | ||
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | a une forme pharmaceutique (attribut) | forme pharmaceutique pour usage parentéral (forme pharmaceutique) | true | Inferred relationship | Some | ||
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | Has product characteristic | Adjuvanted vaccine product (qualifier value) | true | Inferred relationship | Some | ||
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | est un(e) (attribut) | Influenza A virus subtype H1N1 vaccine (product) | false | Inferred relationship | Some | ||
| Arepanrix 3.75 micrograms per 0.5 milliliter suspension and emulsion for injection GlaxoSmithKline Inc (real clinical drug) | a pour principe actif (attribut) | Influenza A virus subtype H1N1 vaccine | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Historical name codes for vaccines reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR